Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“Congratulations to Dr. David Abramson, Chief of the Ophthalmic Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), who was honored with the 2026 Eye Research Prize from the BrightFocus Foundation and the Helen Keller Foundation in recognition of his significant contributions to vision science and advancements in the treatment of childhood eye cancers.
Dr. Abramson has developed pioneering treatments that have transformed the management of eye cancer worldwide. Established in 1994, the Helen Keller Prize for Vision Research recognizes excellence demonstrated through multiple significant research contributions to vision science or a single contribution of exceptional impact.
Learn more about Dr. Abramson’s award.”
More posts about Memorial Sloan Kettering Cancer Center.